SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (768)4/28/1997 11:33:00 PM
From: jay a   of 1762
 
i spoke with inv. rel. contact today. learned there are 2 abstracts in the april '97 edition of AMERICAN JOURNAL OF RESPRITORY AND CRITICAL CARE MEDICINE. i know that's on everyone's favorite reading list. anyway, the abstracts cover idec's work with severe asthmatics (sp?). according to connie, the results are positive. although this will not help in the short-term, it's another reason to own this stock. think about it.....by year end idec could have an approved drug and 2 phase 3 trials ongoing. with 76 million in cash and totally diluted shares out. of about 24 million along with their strong partners i like it even more. remember, buy your straw hats in the winter. the bio-tech mkt. is over-sold by EVERY measure.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext